EQL Pharma AB (publ) (STO:EQL)
Sweden · Delayed Price · Currency is SEK 47.85
+0.05 (0.10%)
At close: May 5, 2026
EQL Pharma AB Market Cap
EQL Pharma AB has a market cap or net worth of 1.41 billion as of May 6, 2026. Its market cap has decreased by -32.34% in one year.
Market Cap
1.41B
Enterprise Value
1.78B
Revenue
425.75M
Ranking
n/a
PE Ratio
48.84
Stock Price
47.85
Market Cap Chart
Since December 17, 2013, EQL Pharma AB's market cap has increased from 78.22M to 1.41B, an increase of 1,706.38%. That is a compound annual growth rate of 26.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 1.41B | -17.21% |
| Dec 30, 2025 | 1.71B | -27.50% |
| Dec 30, 2024 | 2.35B | 142.51% |
| Dec 29, 2023 | 970.72M | 16.78% |
| Dec 30, 2022 | 831.22M | -26.29% |
| Dec 30, 2021 | 1.13B | -2.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 12.01B |
| Cereno Scientific AB | 1.90B |
| Orexo AB | 658.62M |
| Enzymatica AB | 616.55M |
| Dicot Pharma AB | 601.20M |
| Cinclus Pharma Holding AB | 575.21M |
| Nanexa AB | 564.53M |
| Moberg Pharma AB | 540.51M |